CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

/C O R R E C T I O N -- ALZpath, Inc./

PartnershipNeutral
AI Analysis

Summary

ALZpath and Quanterix expanded their strategic licensing agreement to advance next-generation Alzheimer's disease biomarker research. This is a corrected version of a news release originally issued on October 7, 2026.

Outcome Details

Strategic licensing agreement expansion

Importance:2/10
Sentiment:
0.00
partnershiplicensingbiomarkerAlzheimer'scorrection
Related Companies

Read the original article

Published by PR Newswire Biotech on October 8, 2026 9:17 AM

Read Original